{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:49:05Z","timestamp":1761853745954,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T00:00:00Z","timestamp":1628899200000},"content-version":"vor","delay-in-days":105,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.nefroe.2021.08.005","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T16:53:34Z","timestamp":1630774414000},"page":"304-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome"],"prefix":"10.1016","volume":"41","author":[{"given":"Miguel","family":"Liern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anabella","family":"Colazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graciela","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Zotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2021.08.005_bib0005","first-page":"348","article-title":"Consenso sobre factores de riesgo de enfermedad cardiovascular en pediatr\u00eda. Hipertensi\u00f3n arterial en ni\u00f1os y adolescentes","volume":"103","author":"Grupo de Hipertensi\u00f3n","year":"2005","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nefro.2018.05.009","article-title":"Podocituria en pacientes pedi\u00e1tricos con enfermedad de Fabry","volume":"39","author":"Liern","year":"2019","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00000441-200009000-00010","article-title":"Proteinuria: potential causes and approach to evaluation","volume":"320","author":"Wingo","year":"2000","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0020","series-title":"Protocolos Diagn\u00f3stico Terap\u00e9uticos de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Nefrolog\u00eda Pedi\u00e1trica","article-title":"S\u00edndrome nefr\u00f3tico en la edad pedi\u00e1trica","author":"Pe\u00f1a","year":"2008"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0025","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1177\/002215540305101203","article-title":"Actin filament organization of foot process in rat podocytes","volume":"51","author":"Ichimura","year":"2003","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5812\/nephropathol.8110","article-title":"Is it or is it not a pathogenic mutation? Is it or is it not the podocyte?","volume":"1","author":"Sanchez-Ni\u00f1o","year":"2012","journal-title":"J Nephropathol"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0035","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1053\/j.ajkd.2014.08.016","article-title":"Viable podocyturia in healthy individuals: Implications for podocytopathies","volume":"64","author":"Maestroni","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0040","first-page":"F40","article-title":"Urinary excretion of viable podocytes in health and renal disease","volume":"285","author":"Vogelmann","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0045","article-title":"Amiloride as an alternate adjuvant antiproteinuric agent in Fabry disease: the potential roles of plasmin and uPAR","volume":"2014","author":"Trimarchi","year":"2014","journal-title":"Case Rep Nephrol"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0050","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/ndt\/gfr612","article-title":"Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria","volume":"27","author":"Zhang","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000500925","article-title":"Is chronic kidney disease progression influenced by the type of renin-angiotensin-system blocker used?","volume":"143","author":"Silvari\u00f1o","year":"2019","journal-title":"Nephron"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1695-4033(01)77669-2","article-title":"Efecto a largo plazo de los inhibidores de la enzima conversora de angiotensina en ni\u00f1os con proteinuria","volume":"55","author":"Camacho D\u00edaz","year":"2001","journal-title":"An Esp Pediatr"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MNH.0b013e328332bda4","article-title":"Regulation of sodium transport by ENaC in the kidney","volume":"19","author":"Hamm","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0070","doi-asserted-by":"crossref","first-page":"8862","DOI":"10.1073\/pnas.142078099","article-title":"Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication","volume":"99","author":"Alfano","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0075","first-page":"103","article-title":"Primary focal and segmental glomerulosclerosis and suPAR: where do we stand and where are we heading to?","volume":"2","author":"Trimarchi","year":"2013","journal-title":"World J Nephrol"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","article-title":"Idiopathic nephrotic syndrome in children","volume":"392","author":"Noone","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0085","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1681\/ASN.2013020173","article-title":"Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases","volume":"24","author":"Wickman","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0090","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1111\/j.1523-1755.2004.09220.x","article-title":"Why is proteinuria an ominous biomarker of progressive kidney disease?","volume":"66","author":"Zandi-Nejad","year":"2004","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor","volume":"14","author":"Wei","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0100","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrm977","article-title":"uPAR: a versatile signalling orchestrator","volume":"3","author":"Blasi","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0105","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0110","article-title":"Copious podocyturia without proteinuria and with normal renal function in a young adult with Fabry disease","volume":"2015","author":"Trimarchi","year":"2015","journal-title":"Case Rep Nephrol"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ymgme.2010.06.002","article-title":"Age adjusting severity scores for Anderson-Fabry disease","volume":"101","author":"Hughes","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1083\/jcb.139.1.193","article-title":"Synaptopodin: an actinassociated protein in telencephalic dendrites and renal podocytes","volume":"139","author":"Mundel","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nefroe.2021.08.005_bib0125","first-page":"85","article-title":"Podocyturia without proteinuria and with normal renal function in a young adult with Fabry disease","volume":"14","author":"Trimarchi","year":"2016","journal-title":"Rev Nefr Arg"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251421000729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251421000729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:46:02Z","timestamp":1761853562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251421000729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2013251421000729"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2021.08.005","relation":{},"ISSN":["2013-2514"],"issn-type":[{"type":"print","value":"2013-2514"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2021.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2020.11.014","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}